For: | Elsharkawy A, Samir R, El-Kassas M. Fibrosis regression following hepatitis C antiviral therapy. World J Hepatol 2022; 14(6): 1120-1130 [PMID: 35978676 DOI: 10.4254/wjh.v14.i6.1120] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i6/1120.htm |
Number | Citing Articles |
1 |
Jesús García-Bañuelos, Edén Oceguera-Contreras, Ana Sandoval-Rodríguez, Blanca Estela Bastidas-Ramírez, Silvia Lucano-Landeros, Daniela Gordillo-Bastidas, Belinda C. Gómez-Meda, Arturo Santos, Eira Cerda-Reyes, Juan Armendariz-Borunda. AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis. Cells 2023; 12(17): 2127 doi: 10.3390/cells12172127
|
2 |
Laura Huiban, Carol Stanciu, Cristina Maria Muzica, Irina Girleanu, Raluca Avram, Ioana Damian, Robert Nastasa, Ermina Stratina, Sebastian Zenovia, Horia Minea, Remus Stafie, Adrian Rotaru, Ana-Maria Singeap, Stefan Chiriac, Ioana-Miruna Balmus, Anca Trifan. Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological Response. Medicina 2024; 60(9): 1539 doi: 10.3390/medicina60091539
|
3 |
Ana-Maria Muñoz-Restrepo, Maria-Cristina Navas, Jimmy Daza, Marcos Girala, Ezequiel Ridruejo, Guido Gerken, Andreas Teufel. Prevention in Hepatology. Journal of Personalized Medicine 2024; 14(2): 132 doi: 10.3390/jpm14020132
|
4 |
Paulina Czarnecka, Kinga Czarnecka, Olga Tronina, Teresa Bączkowska, Aleksandra Wyczałkowska-Tomasik, Magdalena Durlik, Katarzyna Czerwinska. Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study. Journal of Clinical Medicine 2023; 12(10): 3513 doi: 10.3390/jcm12103513
|
5 |
Marta Paula Pereira Coelho, Thais Pontello de Vries, Aline Marcos Pires, Milena Pereira Parreira, Érika Ramos de Alvarenga, Rodrigo Dias Cambraia, Rodrigo Ribeiro dos Santos, Juliana Maria Trindade Bezerra, Enrico Antonio Colosimo, Gifone Aguiar Rocha, Luciana Diniz Silva. Skeletal muscle mass increases after viral eradication with direct‐acting antivirals in patients with chronic hepatitis C: A longitudinal study. Alimentary Pharmacology & Therapeutics 2024; 59(11): 1387 doi: 10.1111/apt.17950
|
6 |
Elisabetta Caon, Roberta Forlano, Benjamin H. Mullish, Pinelopi Manousou, Krista Rombouts. Sinusoidal Cells in Liver Diseases. 2024; : 513 doi: 10.1016/B978-0-323-95262-0.00025-5
|
7 |
Simone Kresevic, Mauro Giuffrè, Milos Ajcevic, Lory Saveria Crocè, Agostino Accardo. 9th European Medical and Biological Engineering Conference. IFMBE Proceedings 2024; 113: 202 doi: 10.1007/978-3-031-61628-0_22
|
8 |
Mohammed El Behery, AhmedI. Elghwab, Ashraf A. Tabll, Elsherbiny H. Elsayed, Mohamed A. Abdelrazek. Serum collagen IV as a predictor for response to direct-acting antivirals hepatitis C therapy. Journal of Immunoassay and Immunochemistry 2024; 45(6): 539 doi: 10.1080/15321819.2024.2415882
|
9 |
Waleed Attia Hassan, Sherif I. Kamel, Ibrahim Abdel Naby Mahmoud, Nahed Makhlouf, Mahmoud Moubark, Sahar M. Hassany. Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs). Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00284-6
|